Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
Type de publicationJournal Article
Year of Publication2018
AuteursHalmos B., Tan E., Soo R., Cadranel J., Lee M.K, Foucher P., Hsia T., Hochmair M., Griesinger F., Hida T., Kim E., Melosky B., Maerten A., Carcereny E.
JournalJOURNAL OF THORACIC ONCOLOGY
Volume13
PaginationS470-S471
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1556-0864
Mots-clésafatinib, NSCLC
DOI10.1016/j.jtho.2018.08.584